|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.
|
|
3
|
Belpomme D, Irigaray P, Hardell L, Clapp
R, Montagnier L, Epstein S and Sasco AJ: The multitude and
diversity of environmental carcinogens. Environ Res. 105:414–429.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mandal PK: Dioxin: a review of its
environmental effects and its aryl hydrocarbon receptor biology. J
Comp Physiol B. 175:221–230. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schwarz M and Appel KE: Carcinogenic risks
of dioxin: mechanistic considerations. Regul Toxicol Pharmacol.
43:19–34. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whitelaw M, Pongratz I, Wilhelmsson A,
Gustafsson JA and Poellinger L: Ligand-dependent recruitment of the
Arnt coregulator determines DNA recognition by the dioxin receptor.
Mol Cell Biol. 13:2504–2514. 1993.PubMed/NCBI
|
|
7
|
Rowlands JC and Gustafsson JA: Aryl
hydrocarbon receptor-mediated signal transduction. Crit Rev
Toxicol. 27:109–134. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gasiewicz TA: Expression and activity of
aryl hydrocarbon receptors in development and cancer. Crit Rev
Eukaryot Gene Expr. 18:279–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Puga A, Xia Y and Elferink C: Role of the
aryl hydrocarbon receptor in cell cycle regulation. Chem Biol
Interact. 141:117–130. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abdelrahim M, Smith R III and Safe S: Aryl
hydrocarbon receptor gene silencing with small inhibitory RNA
differentially modulates Ah-responsiveness in MCF-7 and HepG2
cancer cells. Mol Pharmacol. 63:1373–1381. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishida M, Mikami S, Kikuchi E, Kosaka T,
Miyajima A, Nakagawa K, Mukai M, Okada Y and Oya M: Activation of
the aryl hydrocarbon receptor pathway enhances cancer cell invasion
by up-regulating the MMP expression and is associated with poor
prognosis in upper urinary tract urothelial cancer. Carcinogenesis.
31:287–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu EL, Yoon D, Choi HH, et al: A proposed
mechanism for the protective effect of dioxin against breast
cancer. Toxicol Sci. 98:436–444. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng TL, Chen J, Mao W, Liu X, Tao Y, Chen
LZ and Chen MH: Potential therapeutic significance of increased
expression of aryl hydrocarbon receptor in human gastric cancer.
World J Gastroenterol. 15:1719–1729. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng TL, Chen J, Mao W, Song X and Chen
MH: Aryl hydrocarbon receptor pathway activation enhances gastric
cancer cell invasiveness likely through a c-Jun-dependent induction
of matrix metalloproteinase-9. BMC Cell Biol. 10:272009. View Article : Google Scholar
|
|
15
|
Nebert DW, Puga A and Vasiliou V: Role of
the Ah receptor and the dioxin-inducible [Ah] gene battery in
toxicity, cancer, and signal transduction. Ann NY Acad Sci.
685:624–640. 1993.PubMed/NCBI
|
|
16
|
Zheng H, Takahashi H, Murai Y, et al:
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth,
invasion, metastasis and angiogenesis of gastric carcinoma.
Anticancer Res. 26:3579–3583. 2006.PubMed/NCBI
|
|
17
|
Lin P, Chang H, Tsai WT, Wu MH, Liao YS,
Chen JT and Su JM: Overexpression of aryl hydrocarbon receptor in
human lung carcinomas. Toxicol Pathol. 31:22–30. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JH, Kim H, Lee KY, et al: Aryl
hydrocarbon receptor gene polymorphisms affect lung cancer risk.
Lung Cancer. 56:9–15. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schlezinger JJ, Liu D, Farago M, Seldin
DC, Belguise K, Sonenshein GE and Sherr DH: A role for the aryl
hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem.
387:1175–1187. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Long JR, Egan KM, Dunning L, et al:
Population-based case-control study of AhR (aryl hydrocarbon
receptor) and CYP1A2 polymorphisms and breast cancer risk.
Pharmacogenet Genomics. 16:237–243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koliopanos A, Kleeff J, Xiao Y, Safe S,
Zimmermann A, Büchler MW and Friess H: Increased arylhydrocarbon
receptor expression offers a potential therapeutic target for
pancreatic cancer. Oncogene. 21:6059–6070. 2002. View Article : Google Scholar
|
|
22
|
Moennikes O, Loeppen S, Buchmann A,
Andersson P, Ittrich C, Poellinger L and Schwarz M: A
constitutively active dioxin/aryl hydrocarbon receptor promotes
hepatocarcinogenesis in mice. Cancer Res. 64:4707–4710. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hillegass JM, Murphy KA, Villano CM and
White LA: The impact of aryl hydrocarbon receptor signaling on
matrix metabolism: implications for development and disease.
Biochem Pharmacol. 387:1159–1173. 2006.PubMed/NCBI
|
|
24
|
Villano CM, Murphy KA, Akintobi A and
White LA: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces
matrix metalloproteinase (MMP) expression and invasion in A2058
melanoma cells. Toxicol Appl Pharmacol. 210:212–224. 2006.
|
|
25
|
Martinez JM, Afshari CA, Bushel PR, Masuda
A, Takahashi T and Walker NJ: Differential toxicogenomic responses
to 2,3,7,8-tetrachlorodibenzo-p-dioxin in malignant and
nonmalignant human airway epithelial cells. Toxicol Sci.
69:409–423. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haque M, Francis J and Sehgal I: Aryl
hydrocarbon exposure induces expression of MMP-9 in human prostate
cancer cell lines. Cancer Lett. 225:159–166. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
28
|
Sier CF, Kubben FJ, Ganesh S, et al:
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are
related to the overall survival of patients with gastric carcinoma.
Br J Cancer. 74:413–417. 1996. View Article : Google Scholar : PubMed/NCBI
|
